Vident Investment Advisory’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,916
Closed -$237K 1306
2022
Q3
$237K Buy
+3,916
New +$124K 0.01% 954
2021
Q3
Sell
-4,389
Closed -$226K 1216
2021
Q2
$226K Buy
+4,389
New +$137K 0.01% 1007
2016
Q2
Sell
-61,666
Closed -$2.54K 391
2016
Q1
$2.54K Buy
+61,666
New +$2.41M 0.16% 262

Other funds holding PRTA

Vident Investment Advisory's PRTA Position: Q4 2022 in Review

Vident Investment Advisory sold out of Prothena Corp (PRTA) in Q4 2022, closing a stake of 3,916 shares — an estimated $237K sold.

Vident Investment Advisory first reported a position in PRTA in Q1 2016 and held it in 3 quarters. The position peaked at $237K in Q3 2022. 201 funds tracked by Wall St. Rank hold PRTA as of Q4 2022.

  • Vident Investment Advisory reported no remaining Prothena Corp position as of Q4 2022 after selling out during the quarter.
  • Vident Investment Advisory sold 3,916 Prothena Corp shares in Q4 2022, an estimated $237K.
  • Vident Investment Advisory first reported a position in Prothena Corp in Q1 2016 and held it in 3 quarters.
  • Vident Investment Advisory's Prothena Corp position peaked at $237K in Q3 2022.
  • 201 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2022.

Based on Vident Investment Advisory's 13F filing for Q4 2022, filed 14 Feb 2023.